-
1 Comment
Beximco Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 0.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Beximco Pharmaceuticals Limited's total revenue rose by 20.7% to $7B since the same quarter in the previous year.
Its net income has increased by 31.6% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 18.4% to $671M since the same quarter in the previous year.
Based on the above factors, Beximco Pharmaceuticals Limited gets an overall score of 3/5.
Exchange | LSE |
---|---|
CurrencyCode | GBP |
ISIN | None |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 170M |
---|---|
PE Ratio | 4.22 |
Target Price | 148 |
Dividend Yield | 6.9% |
Beta | 0.59 |
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BXP.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025